investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Harnessing beneficial off-target effects of kinase inhibitors in lung cancer

Uwe Rix

4 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Uwe Rix

Moffitt Cancer Center

Tampa, United States

University of South Florida

Tampa, United States

Thomas Metz

Oncotest GmbH

Freiburg, Germany

Related projects

Shioko Kimura

Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung

Trachea, bronchus and lung

Pathology

Lesley Katie Seymour

LACE-Bio-II: Identification, Validation and Implementation of Prognostic and/or P

Trachea, bronchus and lung

Pathology

Eric Haura

Specialized Program of Research Excellence (SPORE) in Lung Cancer

Trachea, bronchus and lung

Pathology

Giovanna Tosato

A Role for KSHV in the Pathogenesis of Malignancies

Trachea, bronchus and lung

Pathology

Robert Gillies

Radiomics of Non-Small Cell Lung Cancer (NSCLC)

Trachea, bronchus and lung

Pathology

Philip N. Tsichlis

Differential regulation of RNA processing by Akt isoforms

Trachea, bronchus and lung

Pathology

Characterization of the Biological Activities of Novel Epigenetic Modulators

Trachea, bronchus and lung

Pathology

Martin Mcmahon

Studying the Initiation, Progression and Therapy of Lung Cancer in Mouse Models

Trachea, bronchus and lung

Pathology

Patricia Steeg

Molecular Biology of the Metastatic Phenotype

Trachea, bronchus and lung

Pathology